ALLMedicine™ Follicle-stimulating Hormone Center

Aug 9th, 2022 - The pituitary gonadotropins (Gths), follicle-stimulating hormone (Fsh) and luteinizing hormone (Lh), play critical roles in regulating gonadal development and sexual maturation in vertebrates. We developed non-competitive enzyme-linked immunosorbe...

Jul 24th, 2022 - Testicular sperm aspiration (TESA) is widely used to retrieve sperm from testis. Diagnostic testicular biopsy should not be routinely performed for azoospermia. Therefore, a good predictive model is needed before TESA. A total of 1972 azoospermia ...

Jul 15th, 2022 - High follicle-stimulating hormone (FSH) doses during ovarian stimulation protocols for assisted reproductive technologies (ART) are detrimental to ovulatory follicle function and oocyte quality. However, the mechanisms are unclear. In a small ovar...

Jul 6th, 2022 - Urinary luteinizing hormone (uLH) and urinary follicle-stimulating hormone (uFSH) have been shown to be useful screening and management tools for children with central precocious puberty. However, studies on uLH and uFSH reference intervals are sc...

Jun 22nd, 2022 - Infertility remains a significant public health concern. An issue with controlled ovarian stimulation (COS) is the selection of an exogenous gonadotropin (Gn) regimen, which is mainly based on urinary follicle-stimulating hormone (uFSH), recombina...

Jun 17th, 2022 - Testosterone Gel 1% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as ...

Apr 19th, 2022 - Testosterone Gel 1% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as ...

Apr 8th, 2022 - Testosterone Gel, 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: •Primary hypogonadism (congenital or acquired): testicular failure due to conditions suc...

Mar 30th, 2022 - Testosterone gel 1% is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to crypto...

Feb 8th, 2022 - Testosterone gel, 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such...

Apr 12th, 2021 - A novel therapy combining platelet-rich plasma (PRP) with follicle-stimulating hormone (FSH) that is injected directly into the ovaries has the potential to restore ovarian function for women who experience early menopause, possibly allowing for p...

May 7th, 2018 - Hormones and the Menstrual Cycle The menstrual cycle is accompanied by characteristic hormonal changes.[1] As the activity of the corpus luteum declines, the pituitary release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) incr...

May 7th, 2018 - Hormones and the Menstrual Cycle The menstrual cycle is accompanied by characteristic hormonal changes.[1] As the activity of the corpus luteum declines, the pituitary release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) incr...

Oct 10th, 2017 - Biomarkers used to estimate ovarian reserve were not associated with fertility among women aged 30 to 44 years with no history of infertility who had tried to conceive for 3 months or less, a prospective study has found. "These findings do not sup...

Oct 10th, 2017 - Biomarkers used to estimate ovarian reserve were not associated with fertility among women aged 30 to 44 years with no history of infertility who had tried to conceive for 3 months or less, a prospective study has found. "These findings do not sup...